Cited by

• Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy.

  Wu Y, Zhang W, Liang X, Zhang P, Zhang M, Jiang Y, Cui Y, Chen Y, Zhou W, Liang Q, Dai J, Zhang C, Xu J, Li J, Yu T, Zhang Z, Guo R. Wu Y, et al. J Transl Med. 2025 Apr 3;23(1):393. doi: 10.1186/s12967-024-06057-y. J Transl Med. 2025. PMID: 40181378 Free PMC article.
• Radiomics in breast cancer: Current advances and future directions.

  Qi YJ, Su GH, You C, Zhang X, Xiao Y, Jiang YZ, Shao ZM. Qi YJ, et al. Cell Rep Med. 2024 Sep 17;5(9):101719. doi: 10.1016/j.xcrm.2024.101719. Cell Rep Med. 2024. PMID: 39293402 Free PMC article. Review.
• Development and validation of an MRI spatiotemporal interaction model for early noninvasive prediction of neoadjuvant chemotherapy response in breast cancer: a multicentre study.

  Tang W, Jin C, Kong Q, Liu C, Chen S, Ding S, Liu B, Feng Z, Li Y, Dai Y, Zhang L, Chen Y, Han X, Liu S, Chen D, Weng Z, Liu W, Wei X, Jiang X, Zhou Q, Mao N, Guo Y. Tang W, et al. EClinicalMedicine. 2025 Jun 12;85:103298. doi: 10.1016/j.eclinm.2025.103298. eCollection 2025 Jul. EClinicalMedicine. 2025. PMID: 40584836 Free PMC article.
• Screening of gastric cancer diagnostic biomarkers in the homologous recombination signaling pathway and assessment of their clinical and radiomic correlations.

  Wu A, Hu T, Lai C, Zeng Q, Luo L, Shu X, Huang P, Wang Z, Feng Z, Zhu Y, Cao Y, Li Z. Wu A, et al. Cancer Med. 2024 Aug;13(16):e70153. doi: 10.1002/cam4.70153. Cancer Med. 2024. PMID: 39206620 Free PMC article.
• Radiomics for Predicting Prognostic Factors in Breast Cancer: Insights from Contrast-Enhanced Mammography (CEM).

  Piccolo CL, Sarli M, Pileri M, Tommasiello M, Rofena A, Guarrasi V, Soda P, Beomonte Zobel B. Piccolo CL, et al. J Clin Med. 2024 Oct 29;13(21):6486. doi: 10.3390/jcm13216486. J Clin Med. 2024. PMID: 39518625 Free PMC article.